Cargando…
Recombinant Human Thymosin β4 (rhTβ4) Modulates the Anti-Inflammatory Responses to Alleviate Benzalkonium Chloride (BAC)-Induced Dry Eye Disease
Dry eye disease (DED) is a multifactorial ocular disorder that interferes with daily living and reduces quality of life. However, there is no most ideal therapeutic treatment to address all the deleterious defects of DED. The purpose of this study was to investigate the ability of recombinant human...
Autores principales: | Zhai, Yanfang, Zheng, Xiaoxiang, Mao, Yunyun, Li, Kai, Liu, Yanhong, Gao, Yuemei, Zhao, Mengsu, Yang, Rui, Yu, Rui, Chen, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141377/ https://www.ncbi.nlm.nih.gov/pubmed/35628276 http://dx.doi.org/10.3390/ijms23105458 |
Ejemplares similares
-
Recombinant human thymosin beta‐4 (rhTβ4) improved scalp condition and microbiome homeostasis in seborrheic dermatitis
por: Yu, Rui, et al.
Publicado: (2021) -
Recombinant Human Thymosin Beta-4 Protects against Mouse Coronavirus Infection
por: Yu, Rui, et al.
Publicado: (2021) -
Risk assessment related to the presence of benzalkonium chloride (BAC), didecyldimethyl ammonium chloride (DDAC) and chlorates in fish and fish products
Publicado: (2023) -
Progress on the Function and Application of Thymosin β4
por: Xing, Yuan, et al.
Publicado: (2021) -
Exogenous Thymosin Beta 4 Suppresses IPF-Lung Cancer in Mice: Possibly Associated with Its Inhibitory Effect on the JAK2/STAT3 Signaling Pathway
por: Yu, Rui, et al.
Publicado: (2023)